Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention.

Pencina KM, Thanassoulis G, Wilkins JT, Vasan RS, Navar AM, Peterson ED, Pencina MJ, Sniderman AD.

J Am Coll Cardiol. 2019 Jul 9;74(1):70-79. doi: 10.1016/j.jacc.2019.04.047.

PMID:
31272554
2.

Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.

Enserro DM, Demler OV, Pencina MJ, D'Agostino RB Sr.

Stat Med. 2019 Jun 18. doi: 10.1002/sim.8204. [Epub ahead of print]

PMID:
31211443
3.

Egg Consumption and Risk of Total and Cause-Specific Mortality: An Individual-Based Cohort Study and Pooling Prospective Studies on Behalf of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.

Mazidi M, Katsiki N, Mikhailidis DP, Pencina MJ, Banach M.

J Am Coll Nutr. 2019 Jun 7:1-12. doi: 10.1080/07315724.2018.1534620. [Epub ahead of print]

PMID:
31173548
4.

An outcome model approach to transporting a randomized controlled trial results to a target population.

Goldstein BA, Phelan M, Pagidipati NJ, Holman RR, Pencina MJ, Stuart EA.

J Am Med Inform Assoc. 2019 May 1;26(5):429-437. doi: 10.1093/jamia/ocy188.

PMID:
30869798
5.

Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research.

Navar AM, Peterson ED, Steen DL, Wojdyla DM, Sanchez RJ, Khan I, Song X, Gold ME, Pencina MJ.

JAMA Cardiol. 2019 Mar 6. doi: 10.1001/jamacardio.2019.0198. [Epub ahead of print]

6.

Statistical methods for building better biomarkers of chronic kidney disease.

Pencina MJ, Parikh CR, Kimmel PL, Cook NR, Coresh J, Feldman HI, Foulkes A, Gimotty PA, Hsu CY, Lemley K, Song P, Wilkins K, Gossett DR, Xie Y, Star RA.

Stat Med. 2019 May 20;38(11):1903-1917. doi: 10.1002/sim.8091. Epub 2019 Jan 21.

PMID:
30663113
7.

Single-number summary and decision analytic measures can happily coexist.

Pencina MJ, Steyerberg EW, D'Agostino RB Sr.

Stat Med. 2019 Feb 10;38(3):499-500. doi: 10.1002/sim.8031. No abstract available.

PMID:
30609149
8.

Quantifying Importance of Major Risk Factors for Coronary Heart Disease.

Pencina MJ, Navar AM, Wojdyla D, Sanchez RJ, Khan I, Elassal J, D'Agostino RB Sr, Peterson ED, Sniderman AD.

Circulation. 2019 Mar 26;139(13):1603-1611. doi: 10.1161/CIRCULATIONAHA.117.031855.

9.

On Deep Learning for Medical Image Analysis.

Carin L, Pencina MJ.

JAMA. 2018 Sep 18;320(11):1192-1193. doi: 10.1001/jama.2018.13316. No abstract available.

PMID:
30422287
10.

A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention.

Thanassoulis G, Sniderman AD, Pencina MJ.

JAMA Cardiol. 2018 Nov 1;3(11):1090-1095. doi: 10.1001/jamacardio.2018.3476.

PMID:
30422172
11.

Microsimulation model to predict incremental value of biomarkers added to prognostic models.

Pencina KM, D'Agostino RB, Vasan RS, Pencina MJ.

J Am Med Inform Assoc. 2018 Oct 1;25(10):1382-1385. doi: 10.1093/jamia/ocy108.

PMID:
30169699
12.

Incremental prognostic value of renal function for stroke prediction in atrial fibrillation.

O'Brien EC, Holmes DN, Thomas L, Singer DE, Fonarow GC, Mahaffey KW, Kowey PR, Hylek EM, Pokorney SD, Ansell JE, Pencina MJ, Peterson ED, Piccini JP; ORBIT-AF Patients & Investigators.

Int J Cardiol. 2019 Jan 1;274:152-157. doi: 10.1016/j.ijcard.2018.07.113. Epub 2018 Jul 25.

PMID:
30144994
13.

Deriving Real-World Insights From Real-World Data: Biostatistics to the Rescue.

Pencina MJ, Rockhold FW, D'Agostino RB Sr.

Ann Intern Med. 2018 Sep 18;169(6):401-402. doi: 10.7326/M18-1093. Epub 2018 Jul 24. No abstract available.

PMID:
30039173
14.

Application of net reclassification index to non-nested and point-based risk prediction models: a review.

Thomas LE, O'Brien EC, Piccini JP, D'Agostino RB, Pencina MJ.

Eur Heart J. 2019 Jun 14;40(23):1880-1887. doi: 10.1093/eurheartj/ehy345.

PMID:
29955849
15.

Improving patient risk communication: Translating cardiovascular risk into standardized risk percentiles.

Navar AM, Pencina MJ, Mulder H, Elias P, Peterson ED.

Am Heart J. 2018 Apr;198:18-24. doi: 10.1016/j.ahj.2017.12.005. Epub 2017 Dec 7.

16.

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk.

Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, Broedl UC, Woerle HJ, George JT, von Eynatten M, McGuire DK; CARMELINA® investigators.

Cardiovasc Diabetol. 2018 Mar 14;17(1):39. doi: 10.1186/s12933-018-0682-3.

17.

Absolute vs Additive Net Reclassification Index.

Leening MJG, Pencina MJ.

JAMA. 2018 Feb 13;319(6):616. doi: 10.1001/jama.2017.20541. No abstract available.

PMID:
29450519
18.

Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.

Isakova T, Cai X, Lee J, Xie D, Wang X, Mehta R, Allen NB, Scialla JJ, Pencina MJ, Anderson AH, Talierco J, Chen J, Fischer MJ, Steigerwalt SP, Leonard MB, Hsu CY, de Boer IH, Kusek JW, Feldman HI, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

J Am Soc Nephrol. 2018 Feb;29(2):579-590. doi: 10.1681/ASN.2017070772. Epub 2017 Nov 22.

19.

Authors' response to comments.

Pencina MJ, Chipman J, Steyerberg EW, Braun D, Fine JP, D'Agostino RB Sr.

Stat Med. 2017 Dec 10;36(28):4511-4513. doi: 10.1002/sim.7520. No abstract available.

PMID:
29156502
20.

Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.

Burstein B, Altobelli KK, Williams K, Cannon CP, Pencina MJ, Sniderman AD, Thanassoulis G.

Circulation. 2017 Nov 7;136(19):1860-1862. doi: 10.1161/CIRCULATIONAHA.117.029102. No abstract available.

PMID:
29109198
21.

Scientific, societal, and economic consequences of releasing interim data from clinical trials.

Sharma A, Bigelow RH, Pencina MJ.

Eur Heart J Qual Care Clin Outcomes. 2017 Jan 1;3(1):9-10. doi: 10.1093/ehjqcco/qcw037. No abstract available.

PMID:
28927189
22.

Guideline Recommendations for Statin Therapy-Reply.

Pagidipati NJ, Navar AM, Pencina MJ.

JAMA. 2017 Sep 12;318(10):964. doi: 10.1001/jama.2017.11379. No abstract available.

PMID:
28898376
23.

The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines.

Thanassoulis G, Pencina MJ, Sniderman AD.

JAMA Cardiol. 2017 Nov 1;2(11):1175-1176. doi: 10.1001/jamacardio.2017.2543. No abstract available.

PMID:
28793137
24.

Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis.

Awad K, Mikhailidis DP, Toth PP, Jones SR, Moriarty P, Lip GYH, Muntner P, Catapano AL, Pencina MJ, Rosenson RS, Rysz J, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.

Cardiovasc Drugs Ther. 2017 Aug;31(4):419-431. doi: 10.1007/s10557-017-6743-0. Review.

PMID:
28741244
25.

Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison.

Brennan JM, Thomas L, Cohen DJ, Shahian D, Wang A, Mack MJ, Holmes DR, Edwards FH, Frankel NZ, Baron SJ, Carroll J, Thourani V, Tuzcu EM, Arnold SV, Cohn R, Maser T, Schawe B, Strong S, Stickfort A, Patrick-Lake E, Graham FL, Dai D, Li F, Matsouaka RA, O'Brien S, Li F, Pencina MJ, Peterson ED.

J Am Coll Cardiol. 2017 Jul 25;70(4):439-450. doi: 10.1016/j.jacc.2017.05.060.

26.

Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.

Demler OV, Pencina MJ, Cook NR, D'Agostino RB Sr.

Stat Med. 2017 Sep 20;36(21):3334-3360. doi: 10.1002/sim.7333. Epub 2017 Jun 19.

27.

Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.

Calis KA, Archdeacon P, Bain R, DeMets D, Donohue M, Elzarrad MK, Forrest A, McEachern J, Pencina MJ, Perlmutter J, Lewis RJ.

Clin Trials. 2017 Aug;14(4):342-348. doi: 10.1177/1740774517707743. Epub 2017 May 13.

28.

A comparison of risk prediction methods using repeated observations: an application to electronic health records for hemodialysis.

Goldstein BA, Pomann GM, Winkelmayer WC, Pencina MJ.

Stat Med. 2017 Jul 30;36(17):2750-2763. doi: 10.1002/sim.7308. Epub 2017 May 2.

29.

Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.

Pagidipati NJ, Navar AM, Mulder H, Sniderman AD, Peterson ED, Pencina MJ.

JAMA. 2017 Apr 18;317(15):1563-1567. doi: 10.1001/jama.2017.3416.

30.

Data monitoring committees: Promoting best practices to address emerging challenges.

Fleming TR, DeMets DL, Roe MT, Wittes J, Calis KA, Vora AN, Meisel A, Bain RP, Konstam MA, Pencina MJ, Gordon DJ, Mahaffey KW, Hennekens CH, Neaton JD, Pearson GD, Andersson TL, Pfeffer MA, Ellenberg SS.

Clin Trials. 2017 Apr;14(2):115-123. doi: 10.1177/1740774516688915. Epub 2017 Feb 1.

31.

Erratum to: Methods for evaluating medical tests and biomarkers.

Gopalakrishna G, Langendam M, Scholten R, Bossuyt P, Leeflang M, Noel-Storr A, Thomas J, Marshall I, Wallace B, Whiting P, Davenport C, Leeflang M, GopalaKrishna G, de Salis I, Mallett S, Wolff R, Whiting P, Riley R, Westwood M, Kleinen J, Collins G, Reitsma H, Moons K, Zapf A, Hoyer A, Kramer K, Kuss O, Ensor J, Deeks JJ, Martin EC, Riley RD, Rücker G, Steinhauser S, Schumacher M, Riley R, Ensor J, Snell K, Willis B, Debray T, Moons K, Deeks J, Collins G, di Ruffano LF, Willis B, Davenport C, Mallett S, Taylor-Phillips S, Hyde C, Deeks J, Mallett S, Taylor SA, Batnagar G; STREAMLINE COLON Investigators; STREAMLINE LUNG Investigators; METRIC Investigators, Taylor-Phillips S, Di Ruffano LF, Seedat F, Clarke A, Deeks J, Byron S, Nixon F, Albrow R, Walker T, Deakin C, Hyde C, Zhelev Z, Hunt H, di Ruffano LF, Yang Y, Abel L, Buchanan J, Fanshawe T, Shinkins B, Wynants L, Verbakel J, Van Huffel S, Timmerman D, Van Calster B, Leeflang M, Zwinderman A, Bossuyt P, Oke J, O'Sullivan J, Perera R, Nicholson B, Bromley HL, Roberts TE, Francis A, Petrie D, Mann GB, Malottki K, Smith H, Deeks J, Billingham L, Sitch A, Mallett S, Deeks J, Gerke O, Holm-Vilstrup M, Segtnan EA, Halekoh U, Høilund-Carlsen PF, Francq BG, Deeks J, Sitch A, Dinnes J, Parkes J, Gregory W, Hewison J, Altman D, Rosenberg W, Selby P, Asselineau J, Perez P, Paye A, Bessede E, Proust-Lima C, Naaktgeboren C, de Groot J, Rutjes A, Bossuyt P, Reitsma J, Moons K, Collins G, Ogundimu E, Cook J, Le Manach Y, Altman D, Wynants L, Vergouwe Y, Van Huffel S, Timmerman D, Van Calster B, Pajouheshnia R, Groenwold R, Moons K, Reitsma J, Peelen L, Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW, Cooper J, Taylor-Phillips S, Parsons N, Stinton C, Smith S, Dickens A, Jordan R, Enocson A, Fitzmaurice D, Sitch A, Adab P, Francq BG, Boachie C, Vidmar G, Freeman K, Connock M, Taylor-Phillips S, Court R, Clarke A, de Groot J, Naaktgeboren C, Reitsma H, Moons C, Harris J, Mumford A, Plummer Z, Lee K, Reeves B, Rogers C, Verheyden V, Angelini GD, Murphy GJ, Huddy J, Ni M, Good K, Cooke G, Bossuyt P, Hanna G, Ma J, Altman D, Collins G, Moons KGMC, de Groot JAH, Mallett S, Altman DG, Reitsma JB, Collins GS, Moons KGM, Altman DG, Reitsma JB, Collins GS, Kamarudin AN, Kolamunnage-Dona R, Cox T, Ni M, Huddy J, Borsci S, Hanna G, Pérez T, Pardo MC, Candela-Toha A, Muriel A, Zamora J, Sanghera S, Mohiuddin S, Martin R, Donovan J, Coast J, Seo MK, Cairns J, Mitchell E, Smith A, Wright J, Hall P, Messenger M, Calder N, Wickramasekera N, Vinall-Collier K, Lewington A, Pajouheshnia R, Damen J, Groenwold R, Moons K, Peelen L, Messenger M, Cairns D, Smith A, Hutchinson M, Wright J, Hall P, Calder N, Sturgeon C, Mitchel L, Kift R, Christakoudi S, Rungall M, Mobillo P, Montero R, Tsui TL, Kon SP, Tucker B, Sacks S, Farmer C, Strom T, Chowdhury P, Rebollo-Mesa I, Hernandez-Fuentes M, Damen JAAG, Debray TPA, Heus P, Hooft L, Moons KGM, Pajouheshnia R, Reitsma JB, Scholten RJPM, Damen JAAG, Hooft L, Schuit E, Debray TPA, Collins GS, Tzoulaki I, Lassale CM, Siontis GCM, Chiocchia V, Roberts C, Schlüssel MM, Gerry S, Black JA, Heus P, van der Schouw YT, Peelen LM, Moons KGM, Damen JAAG, Debray TPA, Heus P, Hooft L, Moons KGM, Pajouheshnia R, Reitsma JB, Scholten RJPM, Ma J, Altman D, Collins G, Spence G, McCartney D, van den Bruel A, Lasserson D, Hayward G, Vach W, de Jong A, Burggraaff C, Hoekstra O, Zijlstra J, de Vet H, Hunt H, Hyde C, Graziadio S, Allen J, Johnston L, O'Leary R, Power M, Allen J, Graziadio S, Johnson L, O'Leary R, Power M, Waters R, Simpson J, Johnston L, Allen J, Graziadio S, O'Leary R, Waters R, Power M, Mallett S, Fanshawe TR, Phillips P, Plumb A, Helbren E, Halligan S, Taylor SA, Gale A, Mallett S, Sekula P, Altman DG, Sauerbrei W, Mallett S, Fanshawe TR, Forman JR, Dutton SJ, Takwoingi Y, Hensor EM, Nichols TE, Shinkins B, Yang Y, Abel L, Di Ruffano LF, Fanshawe T, Kempf E, Porcher R, de Beyer J, Moons K, Altman D, Reitsma H, Hopewell S, Sauerbrei W, Collins G, Dennis J, Shields B, Jones A, Henley W, Pearson E, Hattersley A; MASTERMIND consortium, Heus P, Damen JAAG, Pajouheshnia R, Scholten RJPM, Reitsma JB, Collins GS, Altman DG, Moons KGM, Hooft L, Shields B, Dennis J, Jones A, Henley W, Pearson E, Hattersley A; MASTERMIND consortium, Scheibler F, Rummer A, Sturtz S, Großelfinger R, Banister K, Ramsay C, Azuara-Blanco A, Cook J, Boachie C, Burr J, Kumarasamy M, Bourne R, Uchegbu I, Borsci S, Murphy J, Hanna G, Uchegbu I, Carter A, Murphy J, Ni M, Marti J, Eatock J, Uchegbu I, Robotham J, Dudareva M, Gilchrist M, Holmes A, Uchegbu I, Borsci S, Monaghan P, Lord S, StJohn A, Sandberg S, Cobbaert C, Lennartz L, Verhagen-Kamerbeek W, Ebert C, Bossuyt P, Horvath A; Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine, Jenniskens K, Naaktgeboren C, Reitsma J, Moons K, de Groot J, Hyde C, Peters J, Grigore B, Peters J, Hyde C, Hyde C, Ukoumunne O, Peters J, Zhelev Z, Levis B, Benedetti A, Levis AW, Ioannidis JPA, Shrier I, Cuijpers P, Gilbody S, Kloda LA, McMillan D, Patten SB, Steele RJ, Ziegelstein RC, Bombardier CH, Osório FL, Fann JR, Gjerdingen D, Lamers F, Lotrakul M, Loureiro SR, Löwe B, Shaaban J, Stafford L, van Weert HCPM, Whooley MA, Williams LS, Wittkampf KA, Yeung AS, Thombs BD, Peters J, Cooper C, Buchanan J, Nieto T, Smith C, Tucker O, Dretzke J, Beggs A, Rai N, Davenport C, Bayliss S, Stevens S, Snell K, Mallet S, Deeks J, Sundar S, Hall E, Porta N, Estelles DL, de Bono J; CTC-STOP protocol development group.

Diagn Progn Res. 2017 Mar 30;1:11. doi: 10.1186/s41512-017-0011-4. eCollection 2017.

32.

Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.

Xian Y, O'Brien EC, Liang L, Xu H, Schwamm LH, Fonarow GC, Bhatt DL, Smith EE, Olson DM, Maisch L, Hannah D, Lindholm B, Lytle BL, Pencina MJ, Hernandez AF, Peterson ED.

JAMA. 2017 Mar 14;317(10):1057-1067. doi: 10.1001/jama.2017.1371.

PMID:
28291892
33.

Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.

Kopeć G, Waligóra M, Tyrka A, Jonas K, Pencina MJ, Zdrojewski T, Moertl D, Stokwiszewski J, Zagożdżon P, Podolec P.

Sci Rep. 2017 Feb 15;7:41650. doi: 10.1038/srep41650.

34.

Nonparametric estimation and inference for polytomous discrimination index.

Li J, Feng Q, Fine JP, Pencina MJ, Van Calster B.

Stat Methods Med Res. 2018 Oct;27(10):3092-3103. doi: 10.1177/0962280217692830. Epub 2017 Feb 9.

PMID:
28178877
35.

Rejoinder.

Fleming TR, DeMets DL, Roe MT, Wittes J, Calis KA, Vora AN, Meisel A, Bain RP, Konstam MA, Pencina MJ, Gordon DJ, Mahaffey KW, Hennekens CH, Neaton JD, Pearson GD, Andersson TL, Pfeffer MA, Ellenberg SS.

Clin Trials. 2017 Apr;14(2):126-127. doi: 10.1177/1740774516688917. Epub 2017 Jan 31. No abstract available.

36.

Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement.

Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Arnold SV, Kleiman NS, Spertus JA; EVENT Investigators.

Cardiovasc Revasc Med. 2017 Apr - May;18(3):169-176. doi: 10.1016/j.carrev.2016.12.014. Epub 2016 Dec 18.

PMID:
28041858
37.

Estimation of Risk for Initial Atherosclerotic Cardiovascular Disease Events: Taking Stock and Moving Forward.

Wilson PW, Pencina MJ.

Circulation. 2016 Dec 6;134(23):1792-1793. No abstract available.

PMID:
27920071
38.

Determining When to Add Nonstatin Therapy: A Quantitative Approach.

Robinson JG, Huijgen R, Ray K, Persons J, Kastelein JJ, Pencina MJ.

J Am Coll Cardiol. 2016 Dec 6;68(22):2412-2421. doi: 10.1016/j.jacc.2016.09.928. Review.

39.

Controlling for Informed Presence Bias Due to the Number of Health Encounters in an Electronic Health Record.

Goldstein BA, Bhavsar NA, Phelan M, Pencina MJ.

Am J Epidemiol. 2016 Dec 1;184(11):847-855. Epub 2016 Nov 16.

40.

Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence.

Navar AM, Peterson ED, Wojdyla D, Sanchez RJ, Sniderman AD, D'Agostino RB Sr, Pencina MJ.

JAMA. 2016 Nov 15;316(19):2041-2043. doi: 10.1001/jama.2016.13614. No abstract available. Erratum in: JAMA. 2016 Dec 13;316(22):2433.

41.

A comparison of time dependent Cox regression, pooled logistic regression and cross sectional pooling with simulations and an application to the Framingham Heart Study.

Ngwa JS, Cabral HJ, Cheng DM, Pencina MJ, Gagnon DR, LaValley MP, Cupples LA.

BMC Med Res Methodol. 2016 Nov 3;16(1):148.

42.

Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.

Hornik CP, Benjamin DK Jr, Smith PB, Pencina MJ, Tremoulet AH, Capparelli EV, Ericson JE, Clark RH, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act—Pediatric Trials Network.

J Pediatr. 2016 Nov;178:125-129.e1. doi: 10.1016/j.jpeds.2016.07.011. Epub 2016 Aug 10.

43.

Risk Prediction With Electronic Health Records: The Importance of Model Validation and Clinical Context.

Goldstein BA, Navar AM, Pencina MJ.

JAMA Cardiol. 2016 Dec 1;1(9):976-977. doi: 10.1001/jamacardio.2016.3826. No abstract available.

44.

Do Not Over (P) Value Your Research Article.

Thomas LE, Pencina MJ.

JAMA Cardiol. 2016 Dec 1;1(9):1055. doi: 10.1001/jamacardio.2016.3827. No abstract available.

PMID:
27732688
45.

Discrimination slope and integrated discrimination improvement - properties, relationships and impact of calibration.

Pencina MJ, Fine JP, D'Agostino RB Sr.

Stat Med. 2017 Dec 10;36(28):4482-4490. doi: 10.1002/sim.7139. Epub 2016 Oct 3.

PMID:
27699818
46.

Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment.

Navar AM, Pencina MJ, Peterson ED.

JAMA Cardiol. 2016 Nov 1;1(8):864-871. doi: 10.1001/jamacardio.2016.2861.

47.

Open Access Platforms for Sharing Clinical Trial Data--Reply.

Navar AM, Pencina MJ, Peterson ED.

JAMA. 2016 Aug 9;316(6):666-7. doi: 10.1001/jama.2016.8797. No abstract available.

PMID:
27532930
48.

Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms.

Chruściel P, Sahebkar A, Rembek-Wieliczko M, Serban MC, Ursoniu S, Mikhailidis DP, Jones SR, Mosteoru S, Blaha MJ, Martin SS, Rysz J, Toth PP, Lip GY, Pencina MJ, Ray KK, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.

Atherosclerosis. 2016 Oct;253:194-208. doi: 10.1016/j.atherosclerosis.2016.07.897. Epub 2016 Jul 15. Review.

49.

Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.

McGuire DK, Van de Werf F, Armstrong PW, Standl E, Koglin J, Green JB, Bethel MA, Cornel JH, Lopes RD, Halvorsen S, Ambrosio G, Buse JB, Josse RG, Lachin JM, Pencina MJ, Garg J, Lokhnygina Y, Holman RR, Peterson ED; Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) Study Group.

JAMA Cardiol. 2016 May 1;1(2):126-35. doi: 10.1001/jamacardio.2016.0103.

PMID:
27437883
50.

Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.

Fox ER, Samdarshi TE, Musani SK, Pencina MJ, Sung JH, Bertoni AG, Xanthakis V, Balfour PC Jr, Shreenivas SS, Covington C, Liebson PR, Sarpong DF, Butler KR, Mosley TH, Rosamond WD, Folsom AR, Herrington DM, Vasan RS, Taylor HA.

JAMA Cardiol. 2016 Apr 1;1(1):15-25. doi: 10.1001/jamacardio.2015.0300.

Supplemental Content

Loading ...
Support Center